HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sparing the contralateral submandibular gland in oropharyngeal cancer patients: a planning study.

AbstractBACKGROUND AND PURPOSE:
The submandibular glands are proposed to be important in preventing xerostomia in head-and-neck cancer patients. We investigated the feasibility of sparing the contralateral submandibular gland (cSMG) by reducing the dose to the contralateral planning target volume (PTV) and by reducing the clinical target volume (CTV)-to-PTV margin.
MATERIALS AND METHODS:
Ten oropharyngeal cancer patients with a contralateral elective PTV were included in this planning study, using intensity modulated radiotherapy (IMRT). The effect on the mean dose to the cSMG of reducing the dose coverage to the contralateral elective PTV from 95 to 90% of the prescribed dose (54Gy in 1.8Gy daily fractions) was determined. The influence of reducing the margin for position uncertainty from 5 to 2mm was investigated.
RESULTS:
The mean dose to the cSMG was reduced from 54Gy to approximately 40Gy if the dose coverage to the contralateral PTV was reduced to 90% of the prescribed dose. The estimated normal tissue complication probability (NTCP) was reduced below 50%. Reducing the margin from 5 to 2mm resulted in a decrease in the mean dose to the cSMG of approximately 6Gy.
CONCLUSIONS:
Reducing the mean dose to the cSMG below 40Gy is possible with a reasonable dose coverage of the contralateral elective PTV.
AuthorsAntonetta C Houweling, Tim Dijkema, Judith M Roesink, Chris H J Terhaard, Cornelis P J Raaijmakers
JournalRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Radiother Oncol) Vol. 89 Issue 1 Pg. 64-70 (Oct 2008) ISSN: 0167-8140 [Print] Ireland
PMID18501984 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Female
  • Humans
  • Male
  • Neoplasm Staging
  • Oropharyngeal Neoplasms (pathology, radiotherapy)
  • Radiation Dosage
  • Radiation Injuries (prevention & control)
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Submandibular Gland (radiation effects)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: